Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles S Elmore

Showing results (11-20 of 86) with videos related to

Pageof 9
Sort By:
Journal of Labelled Compounds & Radiopharmaceuticals|December 16, 2020
The impact of radiochemistry in drug projects: The use of C-14 label in the AZD8529, AZD7325, and AZD6280 projectsLee Kingston, Chungang Gu, Jian Guo, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|June 15, 2016
Synthesis of [(3) H] and [(2) H6 ]AZD6642, an inhibitor of 5-lipoxygenase activating protein (FLAP)Åsa Lindelöf, Cecilia Ericsson, Roger Simonsson, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|February 23, 2019
Synthesis of di-docosahexaenoyl (C22:6)-bis(monoacylglycerol) phosphate in unlabelled and C-13 labelled forms for use as a biomarker of drug induced phospholipidosisMichael J Hickey, Johnny Lindqvist, Young-Hwan Ha, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|February 27, 2016
Determining the isotopic abundance of a labeled compound by mass spectrometry and how correcting for natural abundance distribution using analogous data from the unlabeled compound leads to a systematic errorDavid J Schenk, William J S Lockley, Charles S Elmore, et al.
Chemical Research in Toxicology|March 1, 2012
Use of radiolabeled compounds in drug metabolism and pharmacokinetic studiesEmre M Isin, Charles S Elmore, Göran N Nilsson, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|January 29, 2017
Isotope labelling by reduction of nitriles: Application to the synthesis of isotopologues of tolmetin and celecoxibKate Ellis-Sawyer, Ryan A Bragg, Nick Bushby, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|August 26, 2016
The synthesis of tritium, carbon-14 and stable isotope labelled selective estrogen receptor degradersRyan A Bragg, Nick Bushby, Cecilia Ericsson, et al.
Angewandte Chemie (International Ed. in English)|August 23, 2023
The Future of (Radio)-Labeled Compounds in Research and Development within the Life Science IndustryVolker Derdau, Charles S Elmore, Thomas Hartung, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 15, 2011
In vitro and in vivo metabolism of a selective δ-opioid receptorJian Guo, Chungang Gu, Diansong Zhou, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|March 22, 2017
Synthesis of 2 C-14 labeled cathepsin C inhibitors: The use of a cyanide to displace a BenzotriazoleLee Kingston, Jonas Bergare, Hans Lönn, et al.
Pageof 9

Showing results (11-20 of 86) with videos related to

Sort By:
Pageof 9
Journal of Labelled Compounds & Radiopharmaceuticals|December 16, 2020
The impact of radiochemistry in drug projects: The use of C-14 label in the AZD8529, AZD7325, and AZD6280 projectsLee Kingston, Chungang Gu, Jian Guo, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|June 15, 2016
Synthesis of [(3) H] and [(2) H6 ]AZD6642, an inhibitor of 5-lipoxygenase activating protein (FLAP)Åsa Lindelöf, Cecilia Ericsson, Roger Simonsson, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|February 23, 2019
Synthesis of di-docosahexaenoyl (C22:6)-bis(monoacylglycerol) phosphate in unlabelled and C-13 labelled forms for use as a biomarker of drug induced phospholipidosisMichael J Hickey, Johnny Lindqvist, Young-Hwan Ha, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|February 27, 2016
Determining the isotopic abundance of a labeled compound by mass spectrometry and how correcting for natural abundance distribution using analogous data from the unlabeled compound leads to a systematic errorDavid J Schenk, William J S Lockley, Charles S Elmore, et al.
Chemical Research in Toxicology|March 1, 2012
Use of radiolabeled compounds in drug metabolism and pharmacokinetic studiesEmre M Isin, Charles S Elmore, Göran N Nilsson, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|January 29, 2017
Isotope labelling by reduction of nitriles: Application to the synthesis of isotopologues of tolmetin and celecoxibKate Ellis-Sawyer, Ryan A Bragg, Nick Bushby, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|August 26, 2016
The synthesis of tritium, carbon-14 and stable isotope labelled selective estrogen receptor degradersRyan A Bragg, Nick Bushby, Cecilia Ericsson, et al.
Angewandte Chemie (International Ed. in English)|August 23, 2023
The Future of (Radio)-Labeled Compounds in Research and Development within the Life Science IndustryVolker Derdau, Charles S Elmore, Thomas Hartung, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 15, 2011
In vitro and in vivo metabolism of a selective δ-opioid receptorJian Guo, Chungang Gu, Diansong Zhou, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|March 22, 2017
Synthesis of 2 C-14 labeled cathepsin C inhibitors: The use of a cyanide to displace a BenzotriazoleLee Kingston, Jonas Bergare, Hans Lönn, et al.
Pageof 9